Latest in Antibodies & Bispecifics

353 words

ANKRD11 restrains CD8+ T cells in hepatitis B and cancer models

A mouse study found that removing ANKRD11 enhanced CD8+ T-cell activity against chronic hepatitis B virus infection and cancer, but human benefits remain untested. Researchers have identified ANKRD11 as a regulator that restrains CD8+ T-cell responses in experimental models of chronic hepatitis B virus…

203 words

VIDEO: Calabrese discusses breakthroughs in neuroimmunology

In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights a recent cover story examining how the practice of rheumatology has changed across generations. Calabrese additionally discussed coverage from the Association of Women in Rheumatology…

Antibodies & Bispecifics

Therapeutic antibodies and their science: monoclonal and bispecific antibodies, T-cell engagers, nanobodies, and how antibody drugs are engineered and discovered.

  • 36 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.